As global healthcare systems, regulators, and payers shift toward a more data-centric decision-making model, the reliance on Real-World Evidence (RWE) has become mission-critical. Traditional registries and manual evidence generation are no longer sufficient to meet the rigorous demands of modern regulatory and payer environments. To stay ahead, organizations must evolve beyond theory and embrace practical, AI-driven methodologies that deliver scalability and real-time insights.
This 60-minute executive webinar explores the cutting edge of evidence generation, focusing on how clinical Natural Language Processing (cNLP) and AI-enabled registries are transforming the entire product lifecycle. Designed for senior leaders in pharmaceutical, biotech, and medical device industries, this session bridges the gap between raw clinical data and regulatory-grade evidence. Participants will gain a strategic perspective on how to utilize unstructured healthcare data to accelerate evidence generation and inform clinical development strategies for 2026 and beyond.
We are honored to welcome Dr. Ignacio H. Medrano as our keynote speaker for this session. A consultant neurologist and a visionary entrepreneur, Dr. Medrano operates at the cutting edge of clinical medicine and artificial intelligence. As the Founder and Chief Medical Officer of Savana, he spearheads the development of advanced Clinical Natural Language Processing (cNLP) to unlock vital insights from unstructured Electronic Health Records on a global scale. Recognized by Forbes as one of the most creative minds in business and a recipient of the Princess of Girona Award, Dr. Medrano brings a wealth of expertise from his background at Singularity University. In this keynote, he will guide us through the evolution of AI-driven research, providing a roadmap to bridge the gap between raw clinical data and regulatory-grade evidence for 2026.

Savana is the global leader in science-level Clinical NLP – delivering multilingual solutions exclusively trained on electronic health records (EHRs). Our comprehensive platform ensures the deepest Regulatory-grade Real-World Evidence, ensuring scientific accuracy, semantic interoperability, and privacy by design.
Core products include Savana Manager Suite (SMS) for structuring hospital data, Savana Data Space (SDS) for federated collaboration, Savana Next Generation Registries (NGRs) for dynamic, longitudinal insight, and the Smart Health Alliance (SHA), a global network for scalable evidence generation. Savana enables hospitals, life sciences, and regulators to unlock value from data, securely, ethically, and with measurable clinical and scientific impact.

What Attendees will Gain
Learn how to leverage clinical Natural Language Processing (cNLP) to transform unstructured Electronic Health Records into high-quality, regulatory-grade evidence.
Discover how next-generation, AI-enabled registries overcome the scalability and timeliness limitations of traditional methods to support rapid decision-making.
Gain a clear roadmap for meeting the mission-critical RWE requirements set by global regulators and HTA bodies for the 2026–2028 cycle.
Understand how to turn real-world clinical narratives into actionable research hypotheses, bridging the gap between clinical practice and development strategy.
Explore practical AI use cases that add value at every stage, from pre-launch evidence building to long-term post-market lifecycle management.
This webinar serves as a strategic preview for the European RWE & Market Access Summit, where you can join industry leaders to master JCA submissions and PICO scoping in person.
